Details
Glautan Indications
Reduction of increased intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Contradictions
Hypersensitivity to the active substance or to other components of the medicinal product.
Dosage & Administration
1 drop of Glautan in the conjunctival sac of the affected eye once a day. The optimal effect is achieved by administering the dose in the evening. Glautan should not be administered more than once a day, as more frequent administration of prostaglandin analogues reduces the effect of reducing elevated IOP.
After instillation, nasolacrimal occlusion or light eyelid closure is recommended. This reduces the systemic absorption of drugs administered to the eye and reduces the likelihood of systemic side effects.
Glautan can be used concomitantly with other topical ophthalmic drugs to reduce IOP. If more than one topical ophthalmic agent is used, the interval between their application should be at least 5 minutes.
If a dose is missed, treatment should be continued from the next scheduled dose. The daily dose should not exceed 1 drop in the affected eye once a day.
If another ophthalmic antiglaucoma agent is replaced with Glautan, another drug should be discontinued and Glautan should be started the next day.
Use in disorders of the liver and kidneys
Travoprost has been studied in patients with hepatic impairment as well as in patients with renal impairment (creatinine clearance below 14 ml / min). No clinically relevant changes in hematology, blood biochemistry, or laboratory urinary parameters were observed in these patients. There is no need to adjust the dose for such patients.
To prevent contamination of the dropper tip and the solution, be careful not to touch the eyelids, adjacent areas or other surfaces with the tip of the dropper bottle.
You have no items to compare.